LDHD anticorps (N-Term)

N° du produit ABIN651920

L’anticorps Lapin Polyclonal anti-LDHD a été validé pour WB, FACS et IHC (p). Il convient pour détecter LDHD dans des échantillons de Humain.

Aperçu rapide pour LDHD anticorps (N-Term) (ABIN651920)

Antigène: LDHD (Lactate Dehydrogenase D (LDHD))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp LDHD est non-conjugé

Application: Western Blotting (WB), Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Clone: RB27170

Détail du produit anti-LDHD anticorps

Épitope: AA 35-62, N-Term

Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.

Immunogène: This LDHD antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 35-62 amino acids from the N-terminal region of human LDHD.

Isotype: Ig Fraction

Information d'application

Indications d'application: WB: 1:1000. IHC-P: 1:50~100. FC: 1:10~50

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.

Date de péremption: 6 months

Détails sur LDHD

Antigène: LDHD (Lactate Dehydrogenase D (LDHD))

Autre désignation: LDHD

Sujet: LDHD belongs to the D-isomer specific 2-hydroxyacid dehydrogenase family. The similar protein in yeast has both D-lactate and D-glycerate dehydrogenase activities. Alternative splicing occurs at this locus and two transcript variants encoding distinct isoforms have been identified. [provided by RefSeq].

Poids moléculaire: 54871

ID gène: 197257

NCBI Accession: NP_705690, NP_919417

UniProt: Q86WU2

Pathways: Ribonucleoside Biosynthetic Process